China Digest: Kirapharma nets $54m; Raysight bags $46m led by Tencent

Kira Pharmaceuticals has garnered $53.5 million in its Series B+ round funding while Raysight has secured nearly 300 million yuan ($46 million) in a Series B round funding led by Tencent.